Trials / Terminated
TerminatedNCT01097447
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,619 (actual)
- Sponsor
- Cxlusa · Industry
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication
Conditions
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2017-04-30
- Completion
- 2017-04-30
- First posted
- 2010-04-01
- Last updated
- 2018-10-11
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01097447. Inclusion in this directory is not an endorsement.